PGIM Private Capital, the $90.6 billion private capital arm of PGIM, had a busy first six months of the year, providing $4.7 billion of senior debt and junior capital to middle-market companies and projects globally, including $3.4 billion from March to June during the COVID-19 pandemic.
According to an announcement from the firm a total of $4.2 billion of investment grade investments and $3.3 billion in global corporate finance investments, across North America, the U.K., Europe, Latin America and Australasia. Roughly $1.4 billion of the whole was invested . . .
Continue Reading
Not a subscriber yet? Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.
Monthly
$30
A pay-as-you-go plan to get you started
→ Instantly unlock all new and archived articles
→ Daily, weekly and monthly e-mail newsletters
Annual
$300
Required for access to AW Research
Get more for less - 20% discount over monthly
→ Everything in Monthly PLUS:
→ Access to articles and data from AW Research
→ AW Annual Investor Compendium – our comprehensive guide to investor activity, with a ranking of the most active investors for the year and profiles of the top global allocators
